Lokelma Side Effects: What to Expect and When to Call Your Doctor

Lokelma (sodium zirconium cyclosilicate) is generally well-tolerated, and clinical trials have shown it has a favorable side effect profile compared to older potassium binders like sodium polystyrene sulfonate. But like any medication, it does carry some risks you should know about.

This guide covers the most important side effects of Lokelma—what's common, what's serious, who's at higher risk, and when you need to contact your doctor.

The Most Common Side Effect: Edema (Fluid Retention)

The most commonly reported side effect of Lokelma in clinical trials is edema—swelling caused by fluid retention, most often in the legs, ankles, and feet. In clinical trials, edema was generally mild to moderate in severity.

Why does Lokelma cause edema? Each 5 g dose of Lokelma contains approximately 400 mg of sodium. At a maintenance dose of 10 g/day, that's 800 mg of extra sodium daily. At the maximum dose of 15 g/day, it's 1,200 mg. For patients who are already fluid-sensitive—especially those with heart failure or advanced kidney disease—this additional sodium load can worsen fluid retention.

Edema was more commonly seen in patients treated with 15 g once daily (the maximum dose) in clinical trials.

Who Is at Higher Risk for Edema?

You may be at higher risk for Lokelma-related edema if you:

• Have heart failure (especially with reduced ejection fraction)
• Have advanced chronic kidney disease (CKD Stage 4–5) or are on dialysis
• Are already on a low-sodium diet for medical reasons
• Are prone to fluid overload for any reason

If you're in one of these groups, your doctor may monitor you more closely, adjust your diuretic dose, or recommend dietary sodium restrictions to offset the sodium added by Lokelma.

Second Most Important: Hypokalemia (Low Potassium)

Lokelma is designed to lower potassium—and it works. That same effectiveness creates a risk of hypokalemia (potassium dropping too low, below 3.5 mmol/L). Hypokalemia can itself cause dangerous cardiac arrhythmias, muscle weakness, and cramping.

Situations that increase hypokalemia risk include:

• Diarrhea or decreased food/fluid intake (reduces potassium intake while the drug continues removing it)
• Taking Lokelma at too high a dose
• Concurrent use of loop diuretics or other potassium-lowering medications

Call your doctor if you experience muscle weakness, leg cramps, fatigue, or palpitations—these can be signs of hypokalemia. Your doctor will monitor your potassium via blood tests and adjust your Lokelma dose as needed.

Gastrointestinal Considerations

Lokelma acts in the gastrointestinal tract—it binds potassium in the small and large intestines. GI side effects are less common with Lokelma than with older potassium binders like Kayexalate, but you should be aware:

• Constipation or GI discomfort: Reported in some patients, though far less common than with SPS
• Contraindicated in GI motility problems: Lokelma should NOT be used if you have severe constipation, bowel obstruction, or fecal impaction. Tell your doctor about any GI motility disorders before starting

Special Considerations: Drug Interactions and Gastric pH

Lokelma transiently increases gastric pH after each dose. This can affect the absorption of other oral medications that depend on stomach acid to dissolve properly—a class known as pH-sensitive drugs.

The general rule: take other oral medications at least 2 hours before or 2 hours after Lokelma. This spacing prevents Lokelma from interfering with how your other drugs are absorbed.

Medications that may be most affected include certain antibiotics (cefpodoxime, cefuroxime), some cancer drugs, and pH-sensitive oral medications. Ask your pharmacist which of your medications require spacing from Lokelma.

Other Things to Know

• Abdominal X-rays: Lokelma may appear on abdominal imaging. Always tell any imaging technician or physician that you are taking Lokelma before abdominal X-rays or CT scans.
• Pregnancy: Lokelma is not absorbed from the GI tract and is not expected to pose risk to a developing fetus. It is also not expected to pass into breast milk. Discuss with your doctor if you are pregnant or breastfeeding.
• Pediatric use: Safety and efficacy of Lokelma in children have not been established. It is approved only for adults.

When to Call Your Doctor

Contact your doctor promptly if you experience:

• Sudden worsening swelling in legs, ankles, or feet (edema)
• Unexplained muscle weakness, cramping, or fatigue (may signal hypokalemia)
• Palpitations or irregular heartbeat
• Diarrhea, vomiting, or significantly reduced eating/drinking (increases hypokalemia risk)
• Worsening shortness of breath or rapid weight gain (signs of fluid overload)

For more on drug-drug interactions with Lokelma, see our companion post: Lokelma Drug Interactions: What to Avoid.